수의용 X선 시장 규모, 점유율 및 동향 분석 리포트 : 솔루션별, 동물별, 기술별, 유형별, 포터빌리티별, 용도별, 최종 용도별, 지역별, 부문 예측(2025-2033년)

Veterinary X-ray Market Summary

The global veterinary X-ray market size was estimated at USD 742.4 million in 2024 and is projected to reach USD 1,315.5 million by 2033, growing at a CAGR of 6.63% from 2025 to 2033. Increasing prevalence of zoonotic diseases, rising demand for imaging devices, rapid technological advancements, and a supportive regulatory environment are some of the factors driving market growth.

The growing prevalence of zoonotic diseases, such as rabies, leptospirosis, and avian influenza, has created a heightened demand for early diagnosis and monitoring in animals. According to a CDC report from April 2025, zoonotic diseases are widespread globally, including in the U.S., with more than 60% of known infectious diseases in humans originating from animals. Additionally, 75% of recently emerging human infectious diseases are linked to animal sources. Thus, animal clinics and hospitals rely on imaging tools, such as X-ray systems, to detect infections, assess internal organ damage, and monitor disease progression. As a result, the need for advanced diagnostic technologies has intensified, driving investments in radiography.

Additionally, animal practitioners have recognized the value of imaging devices for accurate diagnosis, treatment planning, and monitoring recovery in animals. As demand for faster, more reliable, and non-invasive diagnostic methods grows, animal hospitals and clinics are prioritizing the acquisition of X-ray systems. Research in medical imaging systems is also boosting market growth. For instance, in September 2022, the world's largest animal hospital chains, Mars and IVC Evidensia, adopted AI to interpret X-rays amid a radiologist shortage. Trials in North America and Europe allowed rapid analysis of radiographs, supporting rather than replacing specialists. This shift marked a significant step toward AI integration in veterinary diagnostics. The surge in demand for imaging devices is fueled by manufacturers developing advanced, high-resolution systems to cater to the evolving needs of veterinary diagnostics.

Moreover, ongoing technological innovations in animal imaging, such as digital radiography, portable X-ray units, and improved imaging software, have made X-ray systems more efficient, accurate, and user-friendly. For instance, in May 2024, SK Telecom, in collaboration with ATX Medical Solutions, launched its AI-powered veterinary X-ray service, X Caliber, in Australia. This service enables the rapid cloud-based analysis of dog and cat X-rays with an accuracy rate of 86-94%. These advancements reduce procedure time, enhance diagnostic clarity, and enable real-time monitoring, making imaging a vital tool in animal care. As a result, clinics and hospitals are increasingly upgrading to advanced X-ray systems to utilize these benefits. Thus, technological progress in imaging directly drives the adoption of veterinary X-ray devices, as practitioners seek state-of-the-art solutions to enhance diagnostic capabilities and streamline clinical workflows.

Furthermore, the changing regulatory landscape for animal health care is a key factor influencing the veterinary X-ray industry. Enhanced regulations concerning diagnostic precision, radiation safety, and uniform imaging procedures are encouraging animal practices to implement advanced X-ray technologies that meet these standards. According to the USFDA's April 2025 report, the FDA is responsible for animal-use devices but does not require pre-market approval, registration, or post-market reporting. Manufacturers are responsible for ensuring that their devices are safe, effective, and correctly labeled, making compliance with regulations a key obligation of the manufacturer. Regulatory requirements frequently require digital imaging, cloud storage solutions, and accurate reporting, prompting clinics to transition from traditional X-ray machines to AI-enhanced or high-resolution systems. Thus, these regulations are accelerating market growth by increasing demand for modern, compliant animal imaging solutions globally.

Global Veterinary X-ray Market Report Segmentation

This report forecasts revenue growth at the global, regional, and country levels and provides an analysis of the latest industry trends in each of the sub-segments from 2021 to 2033. For this study, Grand View Research has segmented the Veterinary X-ray market report based on solution, portability, technology, type, application, end use, and region:

• Animal Outlook (Revenue, USD Million, 2021 - 2033)
• Small Animals
• Large Animals
• Solution Outlook (Revenue, USD Million, 2021 - 2033)
• Equipment
• Accessories/ Consumables
• PACS
• Technology Outlook (Revenue, USD Million, 2021 - 2033)
• Direct (Capture) Radiography
• Computed Radiography
• Film-based Radiography
• Portability Outlook (Revenue, USD Million, 2021 - 2033)
• Fixed
• Mobile
• Type Outlook (Revenue, USD Million, 2021 - 2033)
• Digital
• Analog
• Application Outlook (Revenue, USD Million, 2021 - 2033)
• Orthopedics and Trauma
• Respiratory
• Gastrointestinal
• Dentistry
• Other Applications
• End Use Outlook (Revenue, USD Million, 2021 - 2033)
• Veterinary Clinics & Hospitals
• Other End Use
• Regional Outlook (Revenue, USD Million, 2021 - 2033)
• North America
  • U.S.
  • Canada
  • Mexico
• Europe
  • UK
  • Germany
  • France
  • Italy
  • Spain
  • Denmark
  • Sweden
  • Norway
• Asia Pacific
  • Japan
  • China
  • India
  • Australia
  • Thailand
  • South Korea
• Latin America
  • Brazil
  • Argentina
• Middle East & Africa
  • South Africa
  • UAE
  • Saudi Arabia
  • Kuwait
  • Qatar
  • Oman

Table of Contents

Chapter 1. Methodology and Scope

• 1.1. Market Segmentation and Scope
• 1.2. Segment Definitions
  • 1.2.1. Animal
  • 1.2.2. Solution
  • 1.2.3. Technology
  • 1.2.4. Type
  • 1.2.5. Portability
  • 1.2.6. Application
  • 1.2.7. End Use
• 1.3. Research Methodology
• 1.4. Information Procurement
  • 1.4.1. Purchased Database
  • 1.4.2. GVR's Internal Database
  • 1.4.3. Secondary Sources
  • 1.4.4. Primary Research
• 1.5. Information/Data Analysis
  • 1.5.1. Data Analysis Models
• 1.6. Market Formulation & Validation
• 1.7. Model Details
  • 1.7.1. Model 1: Commodity Flow Analysis
  • 1.7.2. Model 2: Bottom-Up Analysis
  • 1.7.3. Model 3 Volume-Pricing Analysis
• 1.8. List of Secondary Sources
• 1.9. List Of Abbreviations
• 1.10. Objectives

Chapter 2. Executive Summary

• 2.1. Market Outlook
• 2.2. Segment Outlook
• 2.3. Competitive Insights

Chapter 3. Market Variable Trends & Scope

• 3.1. Market Lineage Outlook
  • 3.1.1. Parent Market Outlook
  • 3.1.2. Ancillary/Related Market Outlook
• 3.2. Market Dynamics
  • 3.2.1. Market Driver Analysis
    • 3.2.1.1. Increasing Prevalence of Zoonotic Diseases
    • 3.2.1.2. Rising Demand for Imaging Devices
    • 3.2.1.3. Supportive Regulatory Environment
    • 3.2.1.4. Rapid Technological Advancements
  • 3.2.2. Market Restraint Analysis
    • 3.2.2.1. High Cost of Devices
    • 3.2.2.2. Lack Of Skilled Veterinarians
  • 3.2.3. Market Opportunity Analysis
  • 3.2.4. Market Challenge Analysis
  • 3.2.5. Technology Landscape
• 3.3. Pricing Model Analysis
• 3.4. Market Analysis Tools
  • 3.4.1. Porter's Five Forces Analysis
  • 3.4.2. PESTEL by SWOT Analysis

Chapter 4. Veterinary X-ray Market: By Animal Estimates & Trend Analysis

• 4.1. Veterinary X-ray Market, By Animal: Segment Dashboard
• 4.2. Veterinary X-ray Market, By Animal Movement Analysis
• 4.3. Veterinary X-ray Market Estimates & Forecasts, by Animal, 2021 to 2033 (USD Million)
• 4.4. Small Animals
  • 4.4.1. Small Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 4.5. Large Animals
  • 4.5.1. Large Animals Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 5. Veterinary X-ray Market: By Solution Estimates & Trend Analysis

• 5.1. Veterinary X-ray Market, By Solution: Segment Dashboard
• 5.2. Veterinary X-ray Market, By Solution Movement Analysis
• 5.3. Veterinary X-ray Market Estimates & Forecasts, by Solution, 2021 to 2033 (USD Million)
• 5.4. Equipment
  • 5.4.1. Equipment Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.5. Accessories/ Consumables
  • 5.5.1. Accessories/ Consumables Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 5.6. PACS
  • 5.6.1. PACS Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 6. Veterinary X-ray Market: By Technology Estimates & Trend Analysis

• 6.1. Veterinary X-ray Market, By Technology: Segment Dashboard
• 6.2. Veterinary X-ray Market, By Technology Movement Analysis
• 6.3. Veterinary X-ray Market Estimates & Forecasts, by Technology, 2021 to 2033 (USD Million)
• 6.4. Direct (Capture) Radiography
  • 6.4.1. Direct (Capture) Radiography Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.5. Computed Radiography
  • 6.5.1. Computed Radiography Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 6.6. Film-based Radiography
  • 6.6.1. Film-based Radiography Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 7. Veterinary X-ray Market: By Portability Estimates & Trend Analysis

• 7.1. Veterinary X-ray Market, By Portability: Segment Dashboard
• 7.2. Veterinary X-ray Market, By Portability Movement Analysis
• 7.3. Veterinary X-ray Market Estimates & Forecasts, by Portability, 2021 to 2033 (USD Million)
• 7.4. Fixed
  • 7.4.1. Fixed Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 7.5. Mobile
  • 7.5.1. Mobile Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 8. Veterinary X-ray Market: By Type Estimates & Trend Analysis

• 8.1. Veterinary X-ray Market, By Type: Segment Dashboard
• 8.2. Veterinary X-ray Market, By Type Movement Analysis
• 8.3. Veterinary X-ray Market Estimates & Forecasts, by Type, 2021 to 2033 (USD Million)
• 8.4. Digital
  • 8.4.1. Digital Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 8.5. Analog
  • 8.5.1. Analog Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 9. Veterinary X-ray Market: By Application Estimates & Trend Analysis

• 9.1. Veterinary X-ray Market, By Application: Segment Dashboard
• 9.2. Veterinary X-ray Market, By Application Movement Analysis
• 9.3. Veterinary X-ray Market Estimates & Forecasts, by Application, 2021 to 2033 (USD Million)
• 9.4. Orthopedics and Trauma
  • 9.4.1. Orthopedics and Trauma Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.5. Respiratory
  • 9.5.1. Respiratory Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.6. Gastrointestinal
  • 9.6.1. Gastrointestinal Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.7. Dentistry
  • 9.7.1. Dentistry Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 9.8. Other Applications
  • 9.8.1. Other Applications Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 10. Veterinary X-ray Market: By End Use Estimates & Trend Analysis

• 10.1. Veterinary X-ray Market, By End Use: Segment Dashboard
• 10.2. Veterinary X-ray Market, By End Use Movement Analysis
• 10.3. Veterinary X-ray Market Estimates & Forecasts, by End Use, 2021 to 2033 (USD Million)
• 10.4. Veterinary Clinics & Hospitals
  • 10.4.1. Veterinary Clinics & Hospitals Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 10.5. Other End Use
  • 10.5.1. Other End Use Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 11. Veterinary X-ray Market: By Regional Estimates & Trend Analysis

• 11.1. Region Market Dashboard
• 11.2. Region Market Share Analysis, 2024 & 2033
• 11.3. North America
  • 11.3.1. North America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.3.2. U.S
    • 11.3.2.1. Key Country Dynamics
    • 11.3.2.2. Competitive Scenario
    • 11.3.2.3. Regulatory Framework
    • 11.3.2.4. U.S. Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.3.3. Canada
    • 11.3.3.1. Key Country Dynamics
    • 11.3.3.2. Competitive Scenario
    • 11.3.3.3. Regulatory Framework
    • 11.3.3.4. Canada Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.3.4. Mexico
    • 11.3.4.1. Key Country Dynamics
    • 11.3.4.2. Competitive Scenario
    • 11.3.4.3. Regulatory Framework
    • 11.3.4.4. Mexico Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.4. Europe
  • 11.4.1. Europe Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.2. UK
    • 11.4.2.1. Key Country Dynamics
    • 11.4.2.2. Competitive Scenario
    • 11.4.2.3. Regulatory Framework
    • 11.4.2.4. UK Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.3. Germany
    • 11.4.3.1. Key Country Dynamics
    • 11.4.3.2. Competitive Scenario
    • 11.4.3.3. Regulatory Framework
    • 11.4.3.4. Germany Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.4. France
    • 11.4.4.1. Key Country Dynamics
    • 11.4.4.2. Competitive Scenario
    • 11.4.4.3. Regulatory Framework
    • 11.4.4.4. France Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.5. Italy
    • 11.4.5.1. Key Country Dynamics
    • 11.4.5.2. Competitive Scenario
    • 11.4.5.3. Regulatory Framework
    • 11.4.5.4. Italy Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.6. Spain
    • 11.4.6.1. Key Country Dynamics
    • 11.4.6.2. Competitive Scenario
    • 11.4.6.3. Regulatory Framework
    • 11.4.6.4. Spain Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.7. Denmark
    • 11.4.7.1. Key Country Dynamics
    • 11.4.7.2. Competitive Scenario
    • 11.4.7.3. Regulatory Framework
    • 11.4.7.4. Denmark Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.8. Sweden
    • 11.4.8.1. Key Country Dynamics
    • 11.4.8.2. Competitive Scenario
    • 11.4.8.3. Regulatory Framework
    • 11.4.8.4. Sweden Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.4.9. Norway
    • 11.4.9.1. Key Country Dynamics
    • 11.4.9.2. Competitive Scenario
    • 11.4.9.3. Regulatory Framework
    • 11.4.9.4. Norway Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.5. Asia Pacific
  • 11.5.1. Asia Pacific Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.2. Japan
    • 11.5.2.1. Key Country Dynamics
    • 11.5.2.2. Competitive Scenario
    • 11.5.2.3. Regulatory Framework
    • 11.5.2.4. Japan Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.3. China
    • 11.5.3.1. Key Country Dynamics
    • 11.5.3.2. Competitive Scenario
    • 11.5.3.3. Regulatory Framework
    • 11.5.3.4. China Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.4. India
    • 11.5.4.1. Key Country Dynamics
    • 11.5.4.2. Competitive Scenario
    • 11.5.4.3. Regulatory Framework
    • 11.5.4.4. India Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.5. Australia
    • 11.5.5.1. Key Country Dynamics
    • 11.5.5.2. Competitive Scenario
    • 11.5.5.3. Regulatory Framework
    • 11.5.5.4. Australia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.6. Thailand
    • 11.5.6.1. Key Country Dynamics
    • 11.5.6.2. Competitive Scenario
    • 11.5.6.3. Regulatory Framework
    • 11.5.6.4. Thailand Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.5.7. South Korea
    • 11.5.7.1. Key Country Dynamics
    • 11.5.7.2. Competitive Scenario
    • 11.5.7.3. Regulatory Framework
    • 11.5.7.4. South Korea Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.6. Latin America
  • 11.6.1. Latin America Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.6.2. Brazil
    • 11.6.2.1. Key Country Dynamics
    • 11.6.2.2. Competitive Scenario
    • 11.6.2.3. Regulatory Framework
    • 11.6.2.4. Brazil Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.6.3. Argentina
    • 11.6.3.1. Key Country Dynamics
    • 11.6.3.2. Competitive Scenario
    • 11.6.3.3. Regulatory Framework
    • 11.6.3.4. Argentina Market Estimates and Forecasts, 2021 - 2033 (USD Million)
• 11.7. MEA
  • 11.7.1. MEA Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.2. South Africa
    • 11.7.2.1. Key Country Dynamics
    • 11.7.2.2. Competitive Scenario
    • 11.7.2.3. Regulatory Framework
    • 11.7.2.4. South Africa Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.3. UAE
    • 11.7.3.1. Key Country Dynamics
    • 11.7.3.2. Competitive Scenario
    • 11.7.3.3. Regulatory Framework
    • 11.7.3.4. UAE Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.4. Saudi Arabia
    • 11.7.4.1. Key Country Dynamics
    • 11.7.4.2. Competitive Scenario
    • 11.7.4.3. Regulatory Framework
    • 11.7.4.4. Saudi Arabia Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.5. Kuwait
    • 11.7.5.1. Key Country Dynamics
    • 11.7.5.2. Competitive Scenario
    • 11.7.5.3. Regulatory Framework
    • 11.7.5.4. Kuwait Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.6. Qatar
    • 11.7.6.1. Key Country Dynamics
    • 11.7.6.2. Competitive Scenario
    • 11.7.6.3. Regulatory Framework
    • 11.7.6.4. Qatar Market Estimates and Forecasts, 2021 - 2033 (USD Million)
  • 11.7.7. Oman
    • 11.7.7.1. Key Country Dynamics
    • 11.7.7.2. Competitive Scenario
    • 11.7.7.3. Regulatory Framework
    • 11.7.7.4. Oman Market Estimates and Forecasts, 2021 - 2033 (USD Million)

Chapter 12. Competitive Landscape

• 12.1. Market Participant Categorization
  • 12.1.1. Market Leaders
  • 12.1.2. Emerging Players
• 12.2. Market Share/Assessment Analysis, 2024 (Heat Map Analysis)
• 12.3. Company Profiles
  • 12.3.1. IDEXX Laboratories, Inc.
    • 12.3.1.1. Participant's Overview
    • 12.3.1.2. Financial Performance
    • 12.3.1.3. Product/Service Benchmarking
    • 12.3.1.4. Strategic Initiatives
  • 12.3.2. Mars, Inc.
    • 12.3.2.1. Participant's Overview
    • 12.3.2.2. Financial Performance
    • 12.3.2.3. Product/Service Benchmarking
    • 12.3.2.4. Strategic Initiatives
  • 12.3.3. Narang Medical Ltd.
    • 12.3.3.1. Participant's Overview
    • 12.3.3.2. Financial Performance
    • 12.3.3.3. Product/Service Benchmarking
    • 12.3.3.4. Strategic Initiatives
  • 12.3.4. FUJIFILM Holdings Corporation
    • 12.3.4.1. Participant's Overview
    • 12.3.4.2. Financial Performance
    • 12.3.4.3. Product/Service Benchmarking
    • 12.3.4.4. Strategic Initiatives
  • 12.3.5. Carestream Health
    • 12.3.5.1. Participant's Overview
    • 12.3.5.2. Financial Performance
    • 12.3.5.3. Product/Service Benchmarking
    • 12.3.5.4. Strategic Initiatives
  • 12.3.6. Mindray Bio-Medical Electronics Co., Ltd.
    • 12.3.6.1. Participant's Overview
    • 12.3.6.2. Financial Performance
    • 12.3.6.3. Product/Service Benchmarking
    • 12.3.6.4. Strategic Initiatives
  • 12.3.7. Midmark Corporation
    • 12.3.7.1. Participant's Overview
    • 12.3.7.2. Financial Performance
    • 12.3.7.3. Product/Service Benchmarking
    • 12.3.7.4. Strategic Initiatives
  • 12.3.8. Canon Medical Systems Corporation
    • 12.3.8.1. Participant's Overview
    • 12.3.8.2. Financial Performance
    • 12.3.8.3. Product/Service Benchmarking
    • 12.3.8.4. Strategic Initiatives
  • 12.3.9. Agfa-Gevaert Group
    • 12.3.9.1. Participant's Overview
    • 12.3.9.2. Financial Performance
    • 12.3.9.3. Product/Service Benchmarking
    • 12.3.9.4. Strategic Initiatives
  • 12.3.10. SEDECAL
    • 12.3.10.1. Participant's Overview
    • 12.3.10.2. Financial Performance
    • 12.3.10.3. Product/Service Benchmarking
    • 12.3.10.4. Strategic Initiatives